BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Influenza
,
Liver
,
Neocentromeres
,
Clofibrate
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MAPK
Summary
General Info
Curated Studies
Most Correlated Studies
Identification and functional analysis of healing regulators in Drosophila
JNK Loss or Gain of Function In Drosophilia Embryos
p38 MAPK overexpression in mouse heart
GRA24 modulation of immune response to infection by sustained host p38 MAPK activation
MDCK cells treated with hepatocyte growth factor and MAPK ERK pathway inhibitors
Explore Curated Studies Results
Literature
Most Relevant Literature
Low entropic cost of binding confers high selectivity on an allosteric ERK2 inhibitor.
Targeting MAPK in Cancer 2.0.
MAPK-Activated Protein Kinases: Servant or Partner?
Evolution of mitogen-activated protein kinase family and their immune function in Apostichopus japon…
Proteome-wide screening for mitogen-activated protein kinase docking motifs and interactors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathw…
Study of D3S-002 as Monotherapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutat…
Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors H…
p38 Mitogen−Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ